scispace - formally typeset
Search or ask a question
Institution

Paris Cardiovascular Research Center

Facility
About: Paris Cardiovascular Research Center is a facility organization based out in . It is known for research contribution in the topics: Medicine & Internal medicine. The organization has 5 authors who have published 7 publications receiving 48 citations.

Papers
More filters
Journal ArticleDOI
TL;DR: In this article , the authors highlighted the substantial heterogeneity present within LVV and the importance of an individualized therapeutic approach, which will enable better disease prognostication, limit treatment-associated adverse effects, and facilitate targeted development and use of novel therapies.
Abstract: Large-vessel vasculitis (LVV) manifests as inflammation of the aorta and its major branches and is the most common primary vasculitis in adults. LVV comprises two distinct conditions, giant cell arteritis and Takayasu arteritis, although the phenotypic spectrum of primary LVV is complex. Non-specific symptoms often predominate and so patients with LVV present to a range of health-care providers and settings. Rapid diagnosis, specialist referral and early treatment are key to good patient outcomes. Unfortunately, disease relapse remains common and chronic vascular complications are a source of considerable morbidity. Although accurate monitoring of disease activity is challenging, progress in vascular imaging techniques and the measurement of laboratory biomarkers may facilitate better matching of treatment intensity with disease activity. Further, advances in our understanding of disease pathophysiology have paved the way for novel biologic treatments that target important mediators of disease in both giant cell arteritis and Takayasu arteritis. This work has highlighted the substantial heterogeneity present within LVV and the importance of an individualized therapeutic approach. Future work will focus on understanding the mechanisms of persisting vascular inflammation, which will inform the development of increasingly sophisticated imaging technologies. Together, these will enable better disease prognostication, limit treatment-associated adverse effects, and facilitate targeted development and use of novel therapies.

42 citations

Journal ArticleDOI
TL;DR: In this paper , the authors aim to describe sex differences in arterial pressure and flow waveform physiology and explore how they may contribute to differences in CVD in women compared to men.
Abstract: Cardiovascular disease (CVD) has long been deemed a disease of old men. However, in 2019 CVD accounted for 35% of all deaths in women and, therefore, remains the leading cause of death in both men and women. There is increasing evidence to show that risk factors, pathophysiology and health outcomes related to CVD differ in women compared with men, yet CVD in women remains understudied, underdiagnosed and undertreated. Differences exist between the sexes in relation to the structure of the heart and vasculature, which translate into differences in blood pressure and flow waveform physiology. These physiological differences between women and men may represent an important explanatory factor contributing to the sex disparity in CVD presentation and outcomes but remain understudied. In this review we aim to describe sex differences in arterial pressure and flow waveform physiology and explore how they may contribute to differences in CVD in women compared to men. Given that unfavourable alterations in the cardiovascular structure and function can start as early as in utero, we report sex differences in waveform physiology across the entire life course.

2 citations

Journal ArticleDOI
TL;DR: Climie et al. as discussed by the authors used the Menzies Institute for Medical Research at the University of Tasmania in Tasmania, Australia to perform medical signal analysis and found that the signal strength was positively correlated with the amount of oxygen in the air.
Abstract: aMenzies Institute for Medical Research, University of Tasmania, Hobart bMedical Signal Analysis, Center for Health & Bioresources, AIT Austrian Institute of Technology, Vienna, Austria Correspondence to Rachel E. Climie, Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart 7000, Australia. E-mail: [email protected]

2 citations

Journal ArticleDOI
TL;DR: The authors found that physiological hypoxia promoted a perinatal-like progenitor state in the adult murine epicardium, and resident epicardial cells retain progenitors identity in adult mammalian heart with self-renewal and multilineage differentiation potential.
Abstract: The epicardium is a reservoir of progenitors that give rise to coronary vasculature and stroma during development and mediates cardiac vascular repair. However, its role as a source of progenitors in the adult mammalian heart remains unclear due to lack of clear lineage markers and single-cell culture systems to elucidate epicardial progeny cell fate. We found that in vivo exposure of mice to physiological hypoxia induced adult epicardial cells to re-enter the cell cycle and to express a subset of developmental genes. Multiplex single cell transcriptional profiling revealed a lineage relationship between epicardial cells and smooth muscle, stromal cells, as well as cells with an endothelial-like fate. We found that physiological hypoxia promoted a perinatal-like progenitor state in the adult murine epicardium. In vitro clonal analyses of purified epicardial cells showed that cell growth and subsequent differentiation is dependent upon hypoxia, and that resident epicardial cells retain progenitor identity in the adult mammalian heart with self-renewal and multilineage differentiation potential. These results point to a source of progenitor cells in the adult heart that can be stimulated in vivo and provide an in vitro model for further studies.

2 citations


Authors
Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20231
20226